Updates on HER2-low breast cancer

Bookmark and Share
Published: 2 Feb 2023
Views: 23
Prof Sana Al Sukhun - University of Jordan, Amman, Jordan

Prof Sana Al Sukhun speaks to ecancer about the latest in HER2-low breast cancer. She discusses the latest in HER2-low BC treatment with trastuzumab and the explores the survival outcomes.

Prof Al Sukhun also speaks about antibody-drug conjugates (ADCs) technologies for management of metastatic breast cancer.